Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$197.96K$197.96Kderived+200.6% vs Q4 2016 Net Income-$2.40M-$2.40MderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$94,167+225.5% Operating Incomederived-$1,497,598N/M Operating Cash Flowderived-$1,209,355N/M Margins · derivedGross margin47.6%+3.6 pt vs Q4 2016
Operating margin-756.5%+1064.5 pt vs Q4 2016
Net margin-1212.9%+2245.4 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 16, 2018 · 75 d after period end